Provided by Tiger Fintech (Singapore) Pte. Ltd.

Boston Scientific

98.92
+3.874.07%
Post-market: 99.240.3700+0.37%19:57 EDT
Volume:12.87M
Turnover:1.28B
Market Cap:146.31B
PE:79.14
High:102.37
Open:100.00
Low:98.43
Close:95.05
Loading ...

Goldman Sachs Thinks These Stocks Are "Insulated" From a Trade War

Dow Jones
·
02 Apr

GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm

Zacks
·
02 Apr

GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech

Zacks
·
02 Apr

Boston Scientific (BSX): Among the Best Healthcare Stocks to Buy According to Billionaires

Insider Monkey
·
01 Apr

ABT Stock to Gain From Early CE Mark Approval of Volt PFA System

Zacks
·
01 Apr

Is This the Right Time to Hold ALGN Stock in Your Portfolio?

Zacks
·
01 Apr

Boston Scientific Announces Conference Call Discussing First Quarter 2025 Results

THOMSON REUTERS
·
01 Apr

Boston Scientific announces conference call discussing first quarter 2025 results

PR Newswire
·
01 Apr

ABT Stock Gains Following the Positive TRILUMINATE Trial Results

Zacks
·
01 Apr

Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

Zacks
·
01 Apr

Positive Outlook for Boston Scientific: Farapulse PFA System Outperforms Competitor in Atrial Arrhythmia Trial

TIPRANKS
·
01 Apr

Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

Zacks
·
01 Apr

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Apr

PAHC vs. BSX: Which Stock Is the Better Value Option?

Zacks
·
31 Mar

Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now!

Insider Monkey
·
31 Mar

Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Simply Wall St.
·
30 Mar

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

Zacks
·
28 Mar

Thermo Fisher's New Deal With CZ Imaging Institute May Boost Its Stock

Zacks
·
28 Mar

IceCure Medical Stock Dips Despite Positive ICESECRET Study Results

Zacks
·
28 Mar

Is Myriad Genetics Stock Worth Holding in Your Portfolio Now?

Zacks
·
28 Mar